Hers vs Luvo Health: FDA-approved Wegovy vs Luvo’s options
Hers vs Luvo Health: quick verdict — Hers emphasizes FDA-approved, brand-name Wegovy® with pricing starting at $149/mo and an active membership requirement; Luvo Health shows clinician-reviewed programs and multiple product formats but current pricing and some details were not verified.
How they differ at a glance
This comparison focuses on the most distinctive supported differences: FDA approval and compounded status, pricing and membership, product formats and dosing support, and clarity on eligibility and state availability. Both firms present clinician review and dose adjustments, but the evidence supplied highlights clear contrasts in FDA-approved brand offerings and published pricing.
Comparison table
| Criteria | Hers | Luvo Health |
|---|---|---|
| FDA-approved brand options | Offers FDA-approved Wegovy® (brand-name semaglutide); not compounded | Offers semaglutide and tirzepatide formats; compounded medications are prepared by licensed pharmacies and are not reviewed or approved by the FDA |
| Starting price published | Wegovy® pill from $149/mo; injectable from $199/mo (price includes medication only if prescribed; membership required) | Starting price not verified on the captured landing page |
| Membership or recurring fee | Active Hers Weight Loss Membership required ($39 first month, auto-renews at $149/month thereafter); medication not available without membership | Not published or could not be verified on the captured landing page |
| Dose support and follow up | Personalized care team with ongoing dose check-ins | Ongoing support and dose changes; dose adjustments based on clinical response |
| Eligibility and state coverage notes | Not available in all 50 states; prescription required; treatment available when a licensed clinician determines it is medically appropriate | Pricing, eligibility, pharmacy, state coverage and renewal terms may change; treatment available when a licensed clinician determines it is medically appropriate |
FDA approval and compounded medication status
Hers explicitly offers FDA-approved Wegovy®, described as a brand-name semaglutide and not a compounded product. The supplier materials repeatedly note no compounded medications for Wegovy®. Luvo Health materials note that compounded medications are prepared by licensed pharmacies and are not reviewed or approved by the FDA. That contrast is central: Hers highlights a brand-name, FDA-approved option while Luvo Health’s captured content includes language about compounded preparations and the regulatory caveat that those products are not FDA-reviewed.
Pricing transparency and membership requirements
Hers publishes starting prices: Wegovy® pill from $149/mo and injectables from $199/mo, and specifies that those prices include medication only if prescribed. Hers also requires an active membership to access medication, with $39 first month and auto-renew at $149/mo thereafter, and notes medication is not available without membership. Luvo Health’s captured landing-page evidence did not publish or verify current starting price or membership details, so direct price comparison is limited to what Hers provides.
Check Hers pricing and membership
Product formats and dose management
Both providers show dose support and clinician review. Hers emphasizes a personalized care team with ongoing dose check-ins for FDA-approved Wegovy®. Luvo Health lists semaglutide injections, semaglutide tablets, and tirzepatide injection and states dose adjustments are based on clinical response and that ongoing support is available. The record for Luvo Health also includes resources and guides about dosing and management.
Eligibility, state availability and regulatory notes
Hers notes prescriptions are required, treatment is available only when a licensed clinician determines it is medically appropriate, and some offerings are not available in all 50 states. Luvo Health’s captured evidence warns pricing, eligibility, pharmacy, state coverage and renewal terms may change and repeats the regulatory note that compounded medications are not FDA-reviewed. Both emphasize clinician review and medical appropriateness; state-by-state availability and exact eligibility criteria are not fully listed for Luvo Health in the captured evidence.
Final comparison and quick conclusion
Hers vs Luvo Health: Hers stands out for published starting prices and an explicit offer of FDA-approved Wegovy® with a required membership and personalized dose check-ins. Luvo Health presents clinician-reviewed programs across semaglutide and tirzepatide formats with ongoing dose adjustments, but captured pricing and some program details were not verified.
Review Luvo Health program details
Choose based on what matters to you
Choose Hers if you want an explicitly FDA-approved brand-name Wegovy® option, published starting prices (Wegovy® pill from $149/mo, injectables from $199/mo), and a described personalized care team with ongoing dose check-ins, understanding an active membership is required and medication access is subject to clinician determination and state availability.
Choose Luvo Health if you prioritize clinician-reviewed programs that include semaglutide and tirzepatide in multiple formats and ongoing dose adjustments, and you will confirm current pricing, pharmacy model and state eligibility because those details were not verified in the captured evidence.
Hers vs Luvo Health: both require clinician review; pick the provider whose model and verified details align with your needs.